| Full Name | Sonya Smith |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 23 E Ross Ave, Sapulpa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457807042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 93650 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sonya Smith, 23 E Ross Ave, Sapulpa, OK 74066-6423 Ph: () - | Sonya Smith, 23 E Ross Ave, Sapulpa, OK 74066-6423 Ph: (918) 216-4999 |
News Archive
According to new research from the American Legacy Foundation as many as nine million adults in the United States are affected by both obesity and smoking, two of the nation's top public health epidemics.
Kronos Longevity Research Institute (KLRI) has announced plans for the Kronos Early Estrogen Prevention Study (KEEPS), a five-year study of female hormone replacement therapy aimed at providing prospective data on the risks and benefits of early menopausal hormonal intervention, particularly as it relates to the progression of atherosclerosis. Atherosclerosis is a medical condition in which fatty material is deposited along the walls of arteries.
About 15% of institutional review board members, who are charged with deciding whether proposed clinical trials are ethical and safe, in the past year were asked to judge at least one proposal involving a drug or medical device company in which they have a financial stake or involving one of those company's competitors, according to a survey published in the New England Journal of Medicine
U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).
› Verified 8 days ago
Ella Ness, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 | |
Katherine Morrison, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 | |
April Lynn Wolfe, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 Fax: 918-216-4998 | |
Sheila Russell, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 615 S Mission St Ste 8, Sapulpa, OK 74066 Phone: 918-224-9310 | |
Barbara Y Taylor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 | |
Donna Ingram, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-216-4999 | |
Miss Kristen Taylor Wagers, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 E Ross Ave, Sapulpa, OK 74066 Phone: 918-277-2016 |